REVLIMID
Live / Registered — Registered and renewed (as of 01 Apr 2026)
What this means for you
Registered since 07 Nov 2006. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Nov 2026).
Record
- Serial number
- 76631301
- Registration number
- 3169244
- Mark type
- Design + words
- Filed
- 14 Feb 2005
- Published for opposition
- 03 Jan 2006
- Registered
- 07 Nov 2006
- Next maintenance due
- 07 Nov 2026
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, namely cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Owner
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
Prior registrations
Prosecution history
- 01 Apr 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 01 Apr 2026 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 01 Apr 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 01 Apr 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Jan 2026 — TEAS SECTION 8 & 9 RECEIVED
- 07 Nov 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Aug 2019 — NOTICE OF SUIT
- 23 Jan 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 23 Jan 2016 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)